Add your Event List View →

Events Calendar (May 2021)

February 5 March 6 April May 1 June 1 July August September 2 October 1 November 2 December 1 January
 
May
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
27
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

28
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

29
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

30
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

1
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

2
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

3
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

4
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

5
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

6
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

7
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

8
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

9
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

10
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

11
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

12
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

13
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

14
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

15
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

16
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

17
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

18
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

19
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

20
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

21
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

22
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

23
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

24
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

Plenareno Diabetes, Obesity and Cholesterol Metabolism

Plenareno Diabetes, Obesity and Cholesterol Metabolism

Plenareno Diabetes, Obesity, and Cholesterol Metabolism Conference (PDOC 2021) will provide the platform for Diabetologists, Endocrinologists, Nutritionists, and other related Professionals to present their latest research works. It aims for invaluable scientific discussions and contributes to the future innovations & recent trends in the areas of Diabetes, Obesity, and Endocrinology and also will bring together an interdisciplinary and global team of research professionals.

Target Audience:

  • Diabetologists
  • Endocrinologists
  • Cardiologists
  • Bariatric Surgeons
  • Nutritionists and Dietitian
  • Physical Therapists
  • Diabetes Educators
  • Podiatrists
  • Clinical Researchers
  • Internists
  • Epidemiologists
  • Exercise Physiologists and Healthcare Researchers

 

EMail: diabetes@plenareno.net

25
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

Plenareno Diabetes, Obesity and Cholesterol Metabolism

Plenareno Diabetes, Obesity and Cholesterol Metabolism

Plenareno Diabetes, Obesity, and Cholesterol Metabolism Conference (PDOC 2021) will provide the platform for Diabetologists, Endocrinologists, Nutritionists, and other related Professionals to present their latest research works. It aims for invaluable scientific discussions and contributes to the future innovations & recent trends in the areas of Diabetes, Obesity, and Endocrinology and also will bring together an interdisciplinary and global team of research professionals.

Target Audience:

  • Diabetologists
  • Endocrinologists
  • Cardiologists
  • Bariatric Surgeons
  • Nutritionists and Dietitian
  • Physical Therapists
  • Diabetes Educators
  • Podiatrists
  • Clinical Researchers
  • Internists
  • Epidemiologists
  • Exercise Physiologists and Healthcare Researchers

 

EMail: diabetes@plenareno.net

26
Advances in Drug Discovery from Hit to Candidate Webinar

Advances in Drug Discovery from Hit to Candidate Webinar

Join us at this virtual conference to learn about new insights and advances that are accelerating drug discovery—from hit to candidate—for small molecules and biologics. Promising hits often have development challenges that require innovative solutions to reach the key milestone of declaring a candidate.

The live webinar format will have one speaker per week, followed by an interactive Q&A session with a global audience.

• Next Gen Computational & AI Approaches
• Small Molecules, Big Advances: Early to Late Lead Op
• Modern Biologics: Antibodies & Cell Therapies
• Advanced Preclinical & Translational Animal Models

27
28
29
30
31
<< April June >>

← Back to List of Events